Publicaciones científicas

/cun/investigacion/publicaciones-cientificas/areaMain/02
  • Reduced Plasma Orexin-A Concentrations are Associated with Cognitive Deficits in Anorexia Nervosa

    Steward T (1,2), Mestre-Bach G (1,2), Granero R (2,3), Sánchez I (1,2), Riesco N (1,2), Vintró-Alcaraz C (1,2), Sauchelli S (1), Jiménez-Murcia S (1,2,4), Agüera Z (1,2), Fernández-García JC (2,5), Garrido-Sánchez L (2,5), Tinahones FJ (2,5), Casanueva FF (2,6), Baños RM (2,7), Botella C (2), Crujeiras AB (2,6), Torre R (2,8,9), Fernández-Real JM (2,10), Frühbeck G (2,11), Ortega FJ (2,10), Rodríguez A (2,11), Menchón JM (1,4,12), Fernández-Aranda F (13,14,15).

    (1) Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
    (2) Ciber Fisiopatologia Obesidad y Nutrición, Instituto Salud Carlos III (Spain), Madrid, Spain.
    (3) Departament de Psicobiologia i Metodologia, Universitat Autònoma de Barcelona, Barcelona, Spain.
    (4) Department of Clinical Sciences, School of Medicine, University of Barcelona, Barcelona, Spain.
    (5) Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga, Hospital Clínico Virgen de la Victoria, Málaga, Spain.
    (6) Molecular and Celular Endocrinology, Instituto de Investigacion Sanitaria (IDIS), Complejo Hospitalario Universitario de Santiago (CHUS) and Santiago de Compostela University (USC), Santiago de Compostela, Spain.
    (7) Department of Psychological, Personality, Evaluation and Treatment of the University of Valencia, Valencia, Spain.
    (8) Integrated Pharmacology and Systems Neurosciences Research Group, Neuroscience Research Program Organization IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
    (9) Department of Health and Experimental Sciences, Universitat Pompeu Fabra Barcelona, Barcelona, Spain.
    (10) Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació, Biomèdica de Girona (IdIBGi), Hospital Dr Josep Trueta, Girona, Spain.
    (11) Metabolic Research Laboratory, Clínica Universidad de Navarra, University of Navarra-IdiSNA, Pamplona, Spain.
    (12) CIBER Salud Mental, Instituto Salud Carlos III (Spain), Madrid, Spain.
    (13) Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
    (14) Ciber Fisiopatologia Obesidad y Nutrición, Instituto Salud Carlos III (Spain), Madrid, Spain.
    (15) Department of Clinical Sciences, School of Medicine, University of Barcelona, Barcelona, Spain.

    Scientific Reports 27 de MAYO de 2019

  • Resección de la primera fila del carpo en pacientes mayores de 50 años: 3 a 16 años de seguimiento

    Montiel V (1), Payo-Ollero J (2), Amillo S (2).

    (1) Departamento Cirugía Ortopédica y Traumatología, Clínica Universidad de Navarra, Pamplona, Navarra, España.
    (2) Departamento Cirugía Ortopédica y Traumatología, Clínica Universidad de Navarra, Pamplona, Navarra, España.

    Revista Española de Cirugía Ortopédica y Traumatología 26 de ABRIL de 2019

  • Randomized phase 3 study of carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible, NDMM patients

    Facon T (1), Lee JH (2), Moreau P (3), Niesvizky R (4), Dimopoulos M (5), Hajek R (6), Pour L (7), Jurczyszyn A (8), Qiu L (9), Klippel Z (10), Zahlten-Kumeli A (10), Osman M (10), Paiva B (11), San-Miguel J (11).

    (1) CHRU Lille Hopital Claude Huriez, Lille, France
    (2) Gachon University Gil Medical Center, Incheon, Korea, Republic of.
    (3) University of Nantes, Nantes, France.
    (4) Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, United States.
    (5) National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
    (6) University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
    (7) University Hospital Brno, Brno, Czech Republic.
    (8) Jagiellonian University, Krakow, Poland.
    (9) Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC State Key Lab of Experimental Hematology, Tianjin, China.
    (10) Amgen Inc., Thousand Oaks, CA, United States.
    (11) Clinica Universidad de Navarra-Centro de Investigacion Medica Aplicada, IDISNA, CIBERONC, Pamplona, Spain.

    Blood 28 de FEBRERO de 2019

  • Risk of complications in patients with conservatively managed ovarian tumours (IOTA5)

    Froyman W (1), Landolfo C (2), De Cock B (3), Wynants L (3), Sladkevicius P (4), Testa AC (5), Van Holsbeke C (6), Domali E (7), Fruscio R (8), Epstein E (9), Dos Santos Bernardo MJ (10), Franchi D (11), Kudla MJ (12), Chiappa V (13), Alcazar JL (14), Leone FPG (15), Buonomo F (16), Hochberg L (17), Coccia ME (18), Guerriero S (19), Deo N (20), Jokubkiene L (4), Kaijser J (21), Coosemans A (22), Vergote I (22), Verbakel JY (23), Bourne T (24), Van Calster B (25), Valentin L (4), Timmerman D (26)

    (1) Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium.
    (2) Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Queen Charlotte's and Chelsea Hospital, Imperial College, London, UK.
    (3) Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
    (4) Department of Obstetrics and Gynecology, Skåne University Hospital Malmö, Lund University, Sweden.
    (5) Department of Woman and Child Health, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore Roma, Rome, Italy.
    (6) Department of Obstetrics and Gynecology, Ziekenhuis Oost-Limburg, Genk, Belgium.
    (7) First Department of Obstetrics and Gynecology, Alexandra Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
    (8) Clinic of Obstetrics and Gynecology, University of Milan-Bicocca, San Gerardo Hospital, Monza, Italy.
    (9) Department of Clinical Science and Education, Karolinska Institutet and Department of Obstetrics and Gynecology, Södersjukhuset, Stockholm, Sweden.
    (10) Department of Obstetrics and Gynecology, Centro Hospitalar Lisboa Central, Lisbon, Portugal.
    (11) Preventive Gynecology Unit, Division of Gynecology, European Institute of Oncology IRCCS, Milan, Italy.
    (12) Department of Perinatology and Oncological Gynecology, School of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
    (13) Department of Gynecologic Oncology, National Cancer Institute of Milan, Milan, Italy.
    (14) Department of Obstetrics and Gynecology, Clinica Universidad de Navarra, School of Medicine, Pamplona, Spain.
    (15) Department of Obstetrics and Gynecology, Biomedical and Clinical Sciences Institute L. Sacco, University of Milan, Milan, Italy.
    (16) Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", Trieste, Italy.
    (17) Imaged Based Gynecology Service, Department of Obstetrics and Gynecology, University of South Florida Morsani College, Tampa, FL, USA.
    (18) Department of Obstetrics and Gynecology, University of Florence, Florence, Italy.
    (19) Department of Obstetrics and Gynecology, University of Cagliari, Policlinico Universitario Duilio Casula, Monserrato, Cagliari, Italy.
    (20) Department of Obstetrics and Gynaecology, Whipps Cross Hospital, London, UK.
    (21) Department of Obstetrics and Gynecology, Ikazia Hospital, Rotterdam, Netherlands.
    (22) Department of Oncology, Leuven Cancer Institute, Laboratory of Tumor Immunology and Immunotherapy, ImmunOvar Research Group, KU Leuven, Leuven, Belgium; Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium.
    (23) Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
    (24) Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium; Queen Charlotte's and Chelsea Hospital, Imperial College, London, UK.
    (25) Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, Netherlands.
    (26) Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium.

    Lancet Oncology 05 de FEBRERO de 2019

  • Respiratory syncytial virus hospitalization in children in northern Spain

    Viguria N (1,2), Martínez-Baz I (2,3,4), Moreno-Galarraga L (1,2), Sierrasesúmaga L (5), Salcedo B (6), Castilla J (2,3,4).

    (1) Department of Pediatrics, Complejo Hospitalario de Navarra, Pamplona, Spain.
    (2) Instituto de Investigación Sanitaria de Navarra, IdiSNA, Pamplona, Spain.
    (3) Instituto de Salud Pública de Navarra, Pamplona, Spain.
    (4) CIBER Epidemiología y Salud Pública, Pamplona, Spain.
    (5) Clínica Universidad de Navarra, Pamplona, Spain.
    (6) Servicio de Gestión, Información y Evaluación, Complejo Hospitalario de Navarra, Pamplona, Spain.

    PLoS One 15 de NOVIEMBRE de 2018

tal vezLE INTERESE

¿QUÉ TECNOLOGÍA UTILIZAMOS?

La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

NUESTROS
PROFESIONALES

Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.

Imagen profesionales de la Clínica Universidad de Navarra

POR QUÉ VENIR
A LA CLÍNICA

Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.

Imagen del edificio de la Clínica Universidad de Navarra